Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunoprecise Antibodies Ltd (NQ: IPA ) 1.050 UNCHANGED Streaming Delayed Price Updated: 3:56 PM EDT, Jun 13, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 34,612 Open 1.040 Bid (Size) 1.050 (115) Ask (Size) 1.070 (5) Prev. Close 1.050 Today's Range 1.040 - 1.080 52wk Range 0.9400 - 3.212 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology June 12, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire BioStrand, ImmunoPrecise Antibodies’ Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery June 10, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Performance YTD -38.24% -38.24% 1 Month -12.50% -12.50% 3 Month -33.96% -33.96% 6 Month -27.59% -27.59% 1 Year -63.16% -63.16% More News Read More EXCLUSIVE: ImmunoPrecise Antibodies' Subsidiary Releases Software With Customizable Interface For AI-Driven Drug Discovery June 10, 2024 Via Benzinga Earnings Outlook For ImmunoPrecise Antibodies March 13, 2024 Via Benzinga Earnings Preview For ImmunoPrecise Antibodies December 13, 2023 Via Benzinga IPA’s Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR) June 04, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results April 22, 2024 Via ACCESSWIRE ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments April 12, 2024 Via ACCESSWIRE InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications March 28, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications March 28, 2024 Via Benzinga IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments March 20, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024 March 14, 2024 Via InvestorPlace IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024* March 14, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Earnings Scheduled For March 14, 2024 March 14, 2024 Via Benzinga ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology March 08, 2024 Via ACCESSWIRE Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 07, 2024 Via Benzinga IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology March 07, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024 March 04, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody Discovery February 13, 2024 Via ACCESSWIRE ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery February 12, 2024 Via Benzinga ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms January 10, 2024 Via ACCESSWIRE ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms January 09, 2024 Via Benzinga IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024 December 14, 2023 Via InvestorPlace IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024* December 14, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Earnings Scheduled For December 14, 2023 December 14, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
